MCAZ

Circular 13 of 2024 – Invitation to attend an online joint Zimbabwe Anaesthetic Association (ZAA) and MCAZ training on the safe use of Hyperbaric (Heavy) Bupivacaine in Spinal anesthesia, on Saturday 8th of June 2024 from 9am – 12:30pm
Circular 13 of 2024 – Invitation to attend an online joint Zimbabwe Anaesthetic Association (ZAA) and MCAZ training on the safe use of Hyperbaric (Heavy) Bupivacaine in Spinal anesthesia, on Saturday 8th of June 2024 from 9am – 12:30pm
Size: 1002KB
Circular 12 of 2024_IMPLEMENTATION PLAN FOR RE-REGISTRATION OF HUMAN ALLOPATHIC MEDICINES RE-REGISTRATION FEES
Circular 12 of 2024_IMPLEMENTATION PLAN FOR RE-REGISTRATION OF HUMAN ALLOPATHIC MEDICINES RE-REGISTRATION FEES
Circular 11 of 2024-SYSTEM CONFIGURATION TO ZIG
Circular 11 of 2024-SYSTEM CONFIGURATION TO ZIG
Size: 167kb
Circular 10 of 2024-Prevention of Diethylene Glycol (DEG) and Ethylene Glycol (EG) Contamination in Pharmaceticals
Circular 10 of 2024-Prevention of Diethylene Glycol (DEG) and Ethylene Glycol (EG) Contamination in Pharmaceticals
Circular 9 of 2024 – Wholesale Dealers Permit Renewals
Circular 9 of 2024 – Wholesale Dealers Permit Renewals
Size: 134KB
Circular 8 of 2024-Upgrade on the MCAZ Imports/Exports Module
Circular 8 of 2024-Upgrade on the MCAZ Imports/Exports Module
Circular 7 of 2024 – Renewal of Premises Licences for Pharmacies
Circular 7 of 2024 – Renewal of Premises Licences for Pharmacies
Size: 1024KB
Circular 6 of 2024 – Notification of the Implemetation Plan for Grouped of Variations and Variation Notification
Circular 6 of 2024 – Notification of the Implemetation Plan for Grouped of Variations and Variation Notification
Circular 5 of 2024 – Publication of Cancelled Wholesale Dealer’s Permits, Pharmacy Licences and Persons’ Licences
Circular 5 of 2024 – Publication of Cancelled Wholesale Dealer’s Permits, Pharmacy Licences and Persons’ Licences
Size: 4MB
Circular 4 of 2024 – Implementation Plan for Re-Registration of Human Allopathic Medicines – Extension of Re-Registration Fee Waiver
Circular 4 of 2024 – Implementation Plan for Re-Registration of Human Allopathic Medicines – Extension of Re-Registration Fee Waiver
Size: 729KB
1 2 3

Loading